Immunological findings during treatment of multiple keratoacanthoma with etretinate
- 1 January 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 114 (1) , 109-116
- https://doi.org/10.1111/j.1365-2133.1986.tb02785.x
Abstract
Treatment with etretinate in a patient with multiple keratoacanthoma is described. Clinical improvement correlated with normalization of IL-2-production and mitogen induced lymphocyte proliferation. A causal relationship between reduced IL-2-production and eruption of keratoacanthoma is suggested.This publication has 12 references indexed in Scilit:
- Keratoacanthoma. A clinical studyArchives of Dermatology, 1984
- Eruptive keratoacanthoma with an internal malignant neoplasmArchives of Dermatology, 1981
- Treatment of Keratoacanthomas with Oral 13-cis-Retinoic AcidNew England Journal of Medicine, 1980
- Separation of functional subsets of human T cells by a monoclonal antibody.Proceedings of the National Academy of Sciences, 1979
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Multiple keratoacanthomas: association with deficient cell mediateted immunityBritish Journal of Dermatology, 1975
- Polyanions and lipopolysaccharide acts on different subpopulations of B cellsNature, 1974
- SKIN CANCER AND IMMUNOSUPPRESSIONThe Lancet, 1971
- Assoziiertes Vorkommen von eruptiven Keratoacanthomen, Tubencarcinom und Paramyeloblastenleuk mieArchives of Dermatological Research, 1970
- Energy Transfer and Radioprotection in Biological SystemsScandinavian Journal of Clinical and Laboratory Investigation, 1968